Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership

2 hours ago 1

Abdul Rahman

Sun, April 19, 2026 astatine 3:51 PM CDT 2 min read

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is among the champion aesculapian AI stocks to bargain now. On March 31, Recursion moved to supercharge its AI-driven cause find level done an expanded concern with Citeline. Citeline is simply a starring supplier of data, analytics, and insights to companies successful the beingness sciences and pharmaceutical industries.

Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership

Why Recursion Pharmaceuticals Inc (RXRX) Expanded Citeline Partnership

As portion of the expanded partnership, Recursion volition adhd Citeline’s real-world information capabilities to its platform. This integration is intended to amended objective proceedings plan and improvement decisions. Recursion uses artificial quality to trim the clip and outgo of processing caller medicines. It’s focused connected processing treatments for crab and uncommon diseases, among others.

The institution doesn’t person a merchandise connected the marketplace yet, but it has a ample pipeline of imaginable cause products. Some are wholly owned projects, portion others are partnered programs involving large cause makers specified arsenic Roche, Merck, Bayer, and Sanofi.

In February past year, Bloomberg reported that Recursion was considered an Amazon Prime-like subscription income exemplary for its drugs erstwhile they deed the market. Under this model, companies could wage a fixed monthly interest to entree Recursion’s postulation of medicines careless of the terms of each drug. This attack could guarantee gross stableness for the company.

At the extremity of 2025, Recursion had received much than $500 cardinal successful milestone payments connected its partnered programs. It estimates aboriginal imaginable milestone payments astatine much than $300 million. The institution closed 2025 with $754 cardinal of currency and currency equivalents, capable to money its operations into aboriginal 2028.

Recursion Pharmaceuticals Inc (NASDAQ:RXRX) is an American clinical-stage biotechnology institution based successful Salt Lake City, Utah. The institution uses a operation of artificial intelligence, instrumentality learning, and different precocious systems to accelerate cause find and development.

While we admit the imaginable of RXRX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: David Abrams’ Hedge Fund Is Betting On These 8 Stocks and 10 Best Energy Storage Stocks to Buy According to Hedge Funds.

Disclosure: None. Follow Insider Monkey connected Google News.

Read Entire Article